share_log

HC Wainwright & Co. Maintains Buy on Agile Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. Maintains Buy on Agile Therapeutics, Lowers Price Target to $3

HC Wainwright&Co.维持买入雅居乐治疗公司,将目标价下调至3美元
Benzinga Real-time News ·  2022/12/30 06:17

HC Wainwright & Co. analyst Oren Livnat maintains Agile Therapeutics (NASDAQ:AGRX) with a Buy and lowers the price target from $5 to $3.

HC Wainwright&Co.分析师Oren Livnat维持雅居乐治疗公司(纳斯达克:AGRX)的买入,并将目标价从5美元下调至3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发